| Jay Craig Starling, MD | |
|
241 Corporate Blvd, Suite 210, Norfolk, VA 23502-4975 | |
| (757) 622-2200 | |
| (757) 965-9493 |
| Full Name | Jay Craig Starling |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 241 Corporate Blvd, Norfolk, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487663290 | NPI | - | NPPES |
| 1322860 | Other | VA | CIGNA |
| 1487663290 | Medicaid | VA | |
| 536778 | Other | VA | ANTHEM BCBS |
| 1487663290 | Other | VA | TRICARE/TRICARE FOR LIFE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 010103435 (Virginia) | Primary |
| Entity Name | Virginia Eye Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992727820 PECOS PAC ID: 6608860978 Enrollment ID: O20040409000511 |
News Archive
Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company has closed a $50 million Series B venture financing. Participants in the funding were current investors in Lux Biosciences, HBM Bioventures, Novo A/S, Prospect Venture Partners and SV Life Sciences (SVLS), as well as SVLS' publicly traded fund, International Biotechnology Trust plc.
Is it better to struggle with moral conflict and ultimately choose to do the right thing or to do the right thing without feeling any turmoil in the first place? New research suggests that your answer may depend on how old you are.
An investigation into the hidden relationship between the American Medical Association and Medicare and how it determines the cost of health care.
Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today exchanged definitive agreements with Malaysian Bio-XCell for the establishment of the Company's industrial biochemical plant and biotechnology R&D facility in Malaysia
Forty years ago, children born with sickle cell disease (SCD) were not expected to live past their teenage years. Today, medical advances are allowing children to live well into adulthood, raising concerns over who is going to care for these patients as adults. However, programs are underway to address these concerns, as reported in the March/April edition of Journal of Pediatric Oncology Nursing, published by the Association of Pediatric Hematology/Oncology Nurses (APHON).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay Craig Starling, MD 241 Corporate Blvd, Suite 210, Norfolk, VA 23502-4975 Ph: (757) 622-2200 | Jay Craig Starling, MD 241 Corporate Blvd, Suite 210, Norfolk, VA 23502-4975 Ph: (757) 622-2200 |
News Archive
Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company has closed a $50 million Series B venture financing. Participants in the funding were current investors in Lux Biosciences, HBM Bioventures, Novo A/S, Prospect Venture Partners and SV Life Sciences (SVLS), as well as SVLS' publicly traded fund, International Biotechnology Trust plc.
Is it better to struggle with moral conflict and ultimately choose to do the right thing or to do the right thing without feeling any turmoil in the first place? New research suggests that your answer may depend on how old you are.
An investigation into the hidden relationship between the American Medical Association and Medicare and how it determines the cost of health care.
Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today exchanged definitive agreements with Malaysian Bio-XCell for the establishment of the Company's industrial biochemical plant and biotechnology R&D facility in Malaysia
Forty years ago, children born with sickle cell disease (SCD) were not expected to live past their teenage years. Today, medical advances are allowing children to live well into adulthood, raising concerns over who is going to care for these patients as adults. However, programs are underway to address these concerns, as reported in the March/April edition of Journal of Pediatric Oncology Nursing, published by the Association of Pediatric Hematology/Oncology Nurses (APHON).
› Verified 9 days ago
Vincent James Verdi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3921 Granby St, Suite A, Norfolk, VA 23504 Phone: 757-583-5826 Fax: 757-588-2712 | |
David M Salib, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Norfolk, VA 23502 Phone: 757-622-2200 Fax: 757-622-4866 | |
Dr. Andrew R Miller, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Norfolk, VA 23502 Phone: 757-663-5348 | |
Dr. Thomas John Joly, MD PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Norfolk, VA 23502 Phone: 757-622-2200 | |
Dr. Kapil Gopal Kapoor, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6160 Kempsville Cir Ste 120b, Norfolk, VA 23502 Phone: 757-481-4400 Fax: 757-481-1285 | |
Esther I-ping Chang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 241 Corporate Blvd, Suite 210, Norfolk, VA 23502 Phone: 757-622-2200 Fax: 757-965-9493 | |
Alaa Al-dabbagh, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6160 Kempsville Cir Ste 120b, Norfolk, VA 23502 Phone: 757-481-4400 Fax: 757-481-1285 |